Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:1225-1227
Published online before print April 2, 2007, doi: 10.1161/HYPERTENSIONAHA.107.089052
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/6/1225    most recent
HYPERTENSIONAHA.107.089052v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmann, M. W.
Right arrow Articles by De Windt, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmann, M. W.
Right arrow Articles by De Windt, L. J.
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Remodeling
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression
Right arrow Myocardial cardiomyopathy disease
Right arrowRelated Article

(Hypertension. 2007;49:1225.)
© 2007 American Heart Association, Inc.


Editorial Commentaries

Linking Cardiac Mechanosensing at the Sarcomere M-Band, Nuclear Factor {kappa}B Signaling, and Cardiac Remodeling

Martin W. Bergmann; Leon J. De Windt

From the Franz-Volhard Clinic (M.W.B.), Department of Cardiology, HELIOS Klinikum-Berlin, Charite Campus Berlin-Buch and Campus Virchow, Berlin, Germany; and the Hubrecht Laboratory and Interuniversity Cardiology Institute Netherlands (L.J.D.W.), Royal Netherlands Academy of Sciences, Utrecht, the Netherlands.

Correspondence to Martin W. Bergmann, Franz Volhard Clinic, HELIOS Kliniken Berlin and Charité Campus Buch, Wiltbergstrasse 50, 13125 Berlin, Germany. E-mail martin.bergmann@charite.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

How the heart senses increased biomechanic stress and converts this "input signal" to generalized downstream cardiac hypertrophy signaling paradigms remains an enigmatic but intriguing question in modern cardiovascular biology. Only recently have signaling molecules that can couple biomechanical stress to common pathways of cardiac hypertrophy been uncovered. Yeast-2-hybrid screens have identified several binding partners of sarcomeric proteins. These concerted actions revealed that especially the sarcomere Z-disc harbors key components that affect the activity of several notable kinases and phosphatase, including mitogen-activated protein kinases, protein kinases A and C, and calcineurin.1 Exemplary to this is the family of calsarcin proteins, which link the Z-disk protein {alpha}-actinin to calcineurin, a well-characterized Ca2+-responsive signaling molecule controlling activity of the transcription factor NFAT and both required and sufficient for cardiac hypertrophy after pleiotropic stimuli (Figure).2 However, interruption of the calcium overload typical for heart failure may not stop disease progression, and, therefore, Ca2+-independent signaling cascades might serve as useful targets to interfere with left ventricular (LV) remodeling on pressure overload or ischemia.3


Figure Removed (Available Only in the Full Text)
View larger version (23K):



 
Hypothetical signaling cascade linking Ang II signaling, cardiac mechanosensing at the sarcomere, and specific transcription factors in LV remodeling.

Likewise, the giant sarcomeric protein titin is the starting point of a signaling complex where the zinc-finger protein nbr1 targets the ubiquitin-associated p62/SQSTM1 to sarcomeres. In turn, p62 interacts with MuRF2, a muscle-specific RING-B-box E3 ligase and ligand of the transactivation domain of the serum response transcription factor. Nuclear translocation of MuRF2, provoked by mechanical inactivity, causes reduction of . . . [Full Text of this Article]


Related Article:

Overexpression of Myofibrillogenesis Regulator-1 Aggravates Cardiac Hypertrophy Induced by Angiotensin II in Mice
Hong-Liang Li, Zhi-Gang She, Tian-Bo Li, Ai-Bing Wang, Qinglin Yang, Yu-Sheng Wei, Yi-Guang Wang, and De-Pei Liu
Hypertension 2007 49: 1399-1408. [Abstract] [Full Text] [PDF]